Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Extraordinary Shows to Long distance race on a Plane - 2The Land Rover Freelander Is Back—But It’s No Longer a Land Rover
- 3Step by step instructions to Get the Best Vehicle Rent Arrangement: Insider Tips and Systems
- 4Unsold Rams May Be Less expensive Than You Suspect
- 5Hitting the brakes: Hubble Space Telescope watches doomed comet reverse its spin
- I went to Japan during peak cherry blossom season and found an easy way to escape the crowds at popular tourist attractions
- A Lone Wolf Outsmarted Hunters in the Black Forest and Then Vanished
- Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
- Survey: Canteen Cups With Great Warm Protection Impact
- Grasping Various Kinds of Local misdemeanors
- Artemis 2 astronauts head for the moon after make-or-break engine burn (video)
- Treasure trove found in Egyptian tomb solves ancient mystery
- 12 times rockets and spacecraft crashed and burned in 2025
- Mom finds out she has cancer after noticing something was off while breastfeeding
